|
ZNF331 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65129999674107E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.88970000150712E-08 |
| Normal-vs-Stage2 |
8.23080004153098E-09 |
| Normal-vs-Stage3 |
1.67850000565295E-09 |
| Normal-vs-Stage4 |
1.88750000074123E-08 |
| Stage1-vs-Stage2 |
2.737600E-01 |
| Stage1-vs-Stage3 |
4.939400E-03 |
| Stage1-vs-Stage4 |
2.474200E-01 |
| Stage2-vs-Stage3 |
2.020800E-01 |
| Stage2-vs-Stage4 |
4.604400E-01 |
| Stage3-vs-Stage4 |
9.067400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27879999922698E-08 |
| Normal-vs-AfricanAmerican |
6.03730000436897E-08 |
| Normal-vs-Asian |
8.88189966019581E-10 |
| Caucasian-vs-AfricanAmerican |
2.600200E-01 |
| Caucasian-vs-Asian |
2.043700E-02 |
| AfricanAmerican-vs-Asian |
6.021000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.41560000388452E-08 |
| Normal-vs-Female |
2.79120000445943E-08 |
| Male-vs-Female |
3.854600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.56230000047941E-08 |
| Normal-vs-Extreme_Weight |
1.71439999974154E-08 |
| Normal-vs-Obese |
2.07600000523556E-08 |
| Normal-vs-Extreme_Obese |
1.0888999701919E-09 |
| Normal_Weight-vs-Extreme_Weight |
9.294400E-01 |
| Normal_Weight-vs-Obese |
7.835000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.541700E-02 |
| Extreme_Weight-vs-Obese |
8.046400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.743980E-02 |
| Obese-vs-Extreme_Obese |
1.474020E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63509999984157E-07 |
| Normal-vs-Age(41-60Yrs) |
1.76700000187324E-08 |
| Normal-vs-Age(61-80Yrs) |
1.39110000185738E-08 |
| Normal-vs-Age(81-100Yrs) |
7.59310000000291E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.373800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.646000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.090000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.220400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.384800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.988200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.23239999819214E-08 |
| Normal-VS-Type2 PRCC |
3.93699994827301E-09 |
| Normal-VS-KIRP CIMP |
3.75419999532056E-08 |
| Normal-VS-Unclassified PRCC |
7.06629998958874E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.442250E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.981400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.412600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.488400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.002000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.526400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.14979972396657E-10 |
| Normal-vs-N1 |
6.24860052589327E-10 |
| Normal-vs-N2 |
6.481400E-03 |
| N0-vs-N1 |
9.997400E-01 |
| N0-vs-N2 |
9.760600E-01 |
| N1-vs-N2 |
9.633000E-01 |
|
|
